Glück Conviction Score™ ⓘ
ARQT
Arcutis Biotherapeutics, Inc.
Effektiv: Neutral
Mittel
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
35,6
35 neu, 101 erhöht, -672781K $ netto
Aktivist
11,9
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 22.59 | +7.9 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 23.79 | +2.5 % vs SMA200 | |
| SMA-Cross | Bärisch | 10 % | DEATH | vor 20 Tagen @ 21.57 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 22.25 | EMA50: 22.54 | |
| MACD-Histogramm | Bullisch | 10 % | 0.459 | Bullisch | |
| RSI(14) | Neutral | 10 % | 64.7 | Neutral (30–70) | |
| Stoch %K(14) | Bärisch | 5 % | 80.2 | Überkauft | |
| ADX(14)+DI | Neutral | 10 % | 18.8 | +DI: 34.6 / −DI: 13.9 | |
| Z-Score(60) | Neutral | 5 % | 1.30 | In Range | |
| 52W-Position | Neutral | 5 % | 62.0 % | Hoch 31.20 / Tief 13.26 | |
| Bollinger(20,2σ) | Bärisch | 5 % | 105.8 % | Upper 24.09 / Mid 21.58 / Lower 19.08 | |
| LinReg-Slope(60) | Neutral | 10 % | -0.0323 | R²=0.16 / annualisiert -36.0 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | Vairavan Latha | Officer, SVP Chief Financial Officer | Open Market Sale | -435 | 21,05 | -9.156,75 | -4,5% | |
| 2026-05-11 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -222 | 21,05 | -4.673,10 | -2,3% | |
| 2026-05-04 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -7.372 | 23,27 | -171.543,49 | -84,8% | |
| 2026-05-04 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -884 | 23,61 | -20.871,77 | -10,3% | |
| 2026-05-04 | Vairavan Latha | Officer, SVP Chief Financial Officer | Open Market Sale | -1.341 | 23,61 | -31.661,81 | -15,6% | |
| 2026-05-04 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -3.172 | 23,61 | -74.892,82 | -37,0% | |
| 2026-05-04 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -684 | 23,61 | -16.149,65 | -8,0% | |
| 2026-05-01 | Welgus Howard G. | Director | Open Market Sale | -7.144 | 22,99 | -164.219,84 | -81,1% | |
| 2026-04-01 | Welgus Howard G. | Director | Open Market Sale | -10.000 | 23,88 | -238.801,00 | -118,0% | |
| 2026-03-02 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -6.106 | 25,16 | -153.629,40 | -75,9% | |
| 2026-03-02 | Welgus Howard G. | Director | Open Market Sale | -10.000 | 25,65 | -256.518,00 | -126,8% | |
| 2026-03-02 | Leonard Keith R | Director | Open Market Sale | -39.272 | 25,39 | -997.194,62 | -492,7% | |
| 2026-03-02 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -6.553 | 25,16 | -164.876,10 | -81,5% | |
| 2026-03-02 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -1.987 | 25,70 | -51.065,90 | -25,2% | |
| 2026-03-02 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -193 | 25,91 | -5.001,38 | -2,5% | |
| 2026-03-02 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -181 | 25,91 | -4.690,43 | -2,3% | |
| 2026-03-02 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -36.281 | 25,16 | -912.851,73 | -451,1% | |
| 2026-03-02 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -1.068 | 25,91 | -27.676,05 | -13,7% | |
| 2026-03-02 | Edwards Larry Todd | Officer, See Remarks | Open Market Sale | -3.584 | 25,16 | -90.177,02 | -44,6% | |
| 2026-03-02 | Edwards Larry Todd | Officer, See Remarks | Open Market Sale | -103 | 25,91 | -2.669,23 | -1,3% | |
| 2026-03-02 | Vairavan Latha | Officer, SVP Chief Financial Officer | Open Market Sale | -2.772 | 25,16 | -69.744,91 | -34,5% | |
| 2026-03-02 | Vairavan Latha | Officer, SVP Chief Financial Officer | Open Market Sale | -81 | 25,91 | -2.099,03 | -1,0% | |
| 2026-02-27 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -3.325 | 27,95 | -92.933,75 | -45,9% | |
| 2026-02-04 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -9.794 | 25,81 | -252.747,88 | -124,9% | |
| 2026-02-02 | Edwards Larry Todd | Officer, See Remarks | Open Market Sale | -2.052 | 25,50 | -52.322,72 | -25,9% | |
| 2026-02-02 | Welgus Howard G. | Director | Open Market Sale | -10.000 | 25,05 | -250.483,00 | -123,8% | |
| 2026-02-02 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -19.833 | 25,50 | -505.709,77 | -249,9% | |
| 2026-02-02 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -19.379 | 25,24 | -489.125,96 | -241,7% | |
| 2026-02-02 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -8.562 | 24,97 | -213.793,14 | -105,6% | |
| 2026-02-02 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -7.983 | 25,50 | -203.553,73 | -100,6% | |
| 2026-02-02 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -4.714 | 25,63 | -120.819,82 | -59,7% | |
| 2026-02-02 | Vairavan Latha | Officer, SVP Chief Financial Officer | Open Market Sale | -1.320 | 25,50 | -33.657,89 | -16,6% | |
| 2026-02-02 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -3.675 | 25,50 | -93.706,62 | -46,3% | |
| 2026-01-05 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -2.490 | 28,98 | -72.165,68 | -35,7% | |
| 2026-01-02 | Welgus Howard G. | Director | Open Market Sale | -10.000 | 28,96 | -289.606,00 | -143,1% | |
| 2025-12-31 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -541 | 28,81 | -15.586,21 | -7,7% | |
| 2025-12-31 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -1.156 | 29,39 | -33.974,03 | -16,8% | |
| 2025-12-15 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -11.500 | 28,94 | -332.851,40 | -164,5% | |
| 2025-12-01 | Welgus Howard G. | Director | Open Market Sale | -10.000 | 30,21 | -302.133,00 | -149,3% | |
| 2025-12-01 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -1.657 | 30,23 | -50.091,11 | -24,8% | |
| 2025-11-24 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -48.945 | 30,36 | -1.485.754,84 | -734,2% | |
| 2025-11-24 | LIN SUE-JEAN | Director | Open Market Sale | -25.272 | 30,78 | -777.955,56 | -384,4% | |
| 2025-11-21 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -1.055 | 30,00 | -31.650,00 | -15,6% | |
| 2025-11-20 | Gilbert Halley E | Director | Open Market Sale | -16.532 | 27,55 | -455.441,72 | -225,0% | |
| 2025-11-19 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -1.561 | 28,50 | -44.488,50 | -22,0% | |
| 2025-11-19 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -989 | 27,95 | -27.646,60 | -13,7% | |
| 2025-11-13 | Krishnamohan Neha | Director | Open Market Sale | -1.232 | 23,37 | -28.791,84 | -14,2% | |
| 2025-11-13 | Krishnamohan Neha | Director | Open Market Sale | -39.272 | 23,19 | -910.701,97 | -450,0% | |
| 2025-11-06 | Edwards Larry Todd | Officer, See Remarks | Open Market Sale | -29.131 | 25,16 | -732.927,22 | -362,2% | |
| 2025-11-06 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -17.250 | 24,18 | -417.144,68 | -206,1% | |
| 2025-11-05 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -3.864 | 23,72 | -91.643,26 | -45,3% | |
| 2025-11-03 | Welgus Howard G. | Director | Open Market Sale | -10.000 | 25,27 | -252.669,00 | -124,9% | |
| 2025-11-03 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -2.607 | 24,71 | -64.425,23 | -31,8% | |
| 2025-11-03 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -15 | 25,40 | -381,00 | -0,2% | |
| 2025-11-03 | Vairavan Latha | Officer, SVP Chief Financial Officer | Open Market Sale | -88 | 24,72 | -2.175,23 | -1,1% | |
| 2025-11-03 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -7.165 | 24,71 | -177.063,63 | -87,5% | |
| 2025-11-03 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -43 | 25,40 | -1.092,14 | -0,5% | |
| 2025-11-03 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -11.478 | 24,71 | -283.646,63 | -140,2% | |
| 2025-11-03 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -69 | 25,40 | -1.752,54 | -0,9% | |
| 2025-10-28 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -40.000 | 25,03 | -1.001.032,00 | -494,6% | |
| 2025-10-02 | Edwards Larry Todd | Officer, See Remarks | Open Market Sale | -297 | 20,78 | -6.171,69 | -3,0% | |
| 2025-10-02 | Edwards Larry Todd | Officer, See Remarks | Open Market Sale | -4.207 | 19,99 | -84.091,62 | -41,6% | |
| 2025-10-02 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -20.739 | 20,04 | -415.574,30 | -205,3% | |
| 2025-10-01 | Welgus Howard G. | Director | Open Market Sale | -9.538 | 18,92 | -180.484,71 | -89,2% | |
| 2025-10-01 | Welgus Howard G. | Director | Open Market Sale | -462 | 18,92 | -8.742,29 | -4,3% | |
| 2025-10-01 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -15.000 | 18,91 | -283.702,50 | -140,2% | |
| 2025-10-01 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -9.261 | 20,02 | -185.371,88 | -91,6% | |
| 2025-09-09 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -504 | 17,52 | -8.829,02 | -4,4% | |
| 2025-09-08 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -9.625 | 17,54 | -168.799,40 | -83,4% | |
| 2025-09-04 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -36.130 | 16,16 | -583.716,28 | -288,4% | |
| 2025-09-02 | Welgus Howard G. | Director | Open Market Sale | -10.000 | 15,64 | -156.383,00 | -77,3% | |
| 2025-08-21 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -2.438 | 15,57 | -37.968,92 | -18,8% | |
| 2025-08-19 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -1.750 | 16,16 | -28.280,70 | -14,0% | |
| 2025-08-08 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -3.847 | 14,03 | -53.988,41 | -26,7% | |
| 2025-08-04 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -11.547 | 14,33 | -165.429,25 | -81,7% | |
| 2025-08-04 | Vairavan Latha | Officer, SVP Chief Financial Officer | Open Market Sale | -89 | 14,33 | -1.275,07 | -0,6% | |
| 2025-08-04 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -2.622 | 14,33 | -37.564,35 | -18,6% | |
| 2025-08-04 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -6.330 | 14,33 | -90.687,38 | -44,8% | |
| 2025-08-01 | Welgus Howard G. | Director | Open Market Sale | -3.890 | 14,30 | -55.620,00 | -27,5% | |
| 2025-08-01 | Welgus Howard G. | Director | Open Market Sale | -6.110 | 14,30 | -87.362,00 | -43,2% | |
| 2025-07-14 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -5.750 | 15,07 | -86.653,65 | -42,8% | |
| 2025-07-10 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -23.000 | 15,05 | -346.046,50 | -171,0% | |
| 2025-07-01 | Welgus Howard G. | Director | Open Market Sale | -9.208 | 13,84 | -127.430,43 | -63,0% | |
| 2025-06-18 | Welgus Howard G. | Director | Open Market Sale | -10.139 | 13,37 | -135.573,64 | -67,0% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 12.327.000 | 11.964.000 | 363.000 | 290.424.120 | Aufgestockt | +3,0% | |
| Frazier Life Sciences Management, L.P. | 9.874.511 | 9.874.511 | 0 | 232.643.479 | Unverändert | 0,0% | |
| BlackRock, Inc. | 9.200.411 | 9.099.579 | 100.832 | 216.761.686 | Aufgestockt | +1,1% | |
| VANGUARD GROUP INC | 7.253.936 | 0 | 7.253.936 | 210.654.301 | Neu | +100,0% | |
| Rubric Capital Management LP | 8.271.577 | 8.271.577 | 0 | 194.878.354 | Unverändert | 0,0% | |
| STATE STREET CORP | 6.296.197 | 5.488.301 | 807.896 | 148.338.401 | Aufgestockt | +14,7% | |
| Polar Capital Holdings Plc | 5.666.940 | 5.556.169 | 110.771 | 133.513.106 | Aufgestockt | +2,0% | |
| JENNISON ASSOCIATES LLC | 4.980.770 | 6.758.006 | -1.777.236 | 117.346.943 | Reduziert | -26,3% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.871.536 | 0 | 4.871.536 | 114.773.388 | Neu | +100,0% | |
| GILDER GAGNON HOWE & CO LLC | 4.304.010 | 4.453.856 | -149.846 | 101.402.476 | Reduziert | -3,4% | |
| MORGAN STANLEY | 4.218.931 | 4.340.239 | -121.308 | 99.398.031 | Reduziert | -2,8% | |
| UBS Group AG | 3.329.224 | 3.243.432 | 85.792 | 78.436.518 | Aufgestockt | +2,6% | |
| GEODE CAPITAL MANAGEMENT, LLC | 3.045.306 | 2.753.307 | 291.999 | 71.759.223 | Aufgestockt | +10,6% | |
| D. E. Shaw & Co., Inc. | 2.496.222 | 2.683.087 | -186.865 | 58.810.990 | Reduziert | -7,0% | |
| MARSHALL WACE, LLP | 2.431.778 | 454.233 | 1.977.545 | 57.292.689 | Aufgestockt | +435,4% | |
| FRANKLIN RESOURCES INC | 2.297.943 | 1.900.084 | 397.859 | 54.139.548 | Aufgestockt | +20,9% | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2.226.029 | 2.562.445 | -336.416 | 52.445.243 | Reduziert | -13,1% | |
| BANK OF AMERICA CORP /DE/ | 2.221.289 | 1.673.454 | 547.835 | 52.333.569 | Aufgestockt | +32,7% | |
| JANUS HENDERSON GROUP PLC | 1.854.566 | 1.830.061 | 24.505 | 43.684.303 | Aufgestockt | +1,3% | |
| GOLDMAN SACHS GROUP INC | 1.603.013 | 1.576.413 | 26.600 | 37.766.986 | Aufgestockt | +1,7% | |
| AMERICAN CENTURY COMPANIES INC | 1.463.228 | 1.467.176 | -3.948 | 34.473.689 | Reduziert | -0,3% | |
| OBERWEIS ASSET MANAGEMENT INC/ | 1.365.941 | 808.400 | 557.541 | 32.181.570 | Aufgestockt | +69,0% | |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.355.892 | 1.366.624 | -10.732 | 31.944.816 | Reduziert | -0,8% | |
| Ensign Peak Advisors, Inc | 1.244.387 | 1.902.390 | -658.003 | 29.317.758 | Reduziert | -34,6% | |
| Squarepoint Ops LLC | 1.103.490 | 455.876 | 647.614 | 25.998.224 | Aufgestockt | +142,1% | |
| Candriam S.C.A. | 1.086.651 | 803.138 | 283.513 | 25.601.498 | Aufgestockt | +35,3% | |
| FEDERATED HERMES, INC. | 1.077.267 | 891.767 | 185.500 | 25.380.411 | Aufgestockt | +20,8% | |
| BAMCO INC /NY/ | 1.072.189 | 504.700 | 567.489 | 25.260.773 | Aufgestockt | +112,4% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.012.555 | 1.014.826 | -2.271 | 23.855.796 | Reduziert | -0,2% | |
| NORTHERN TRUST CORP | 976.512 | 955.235 | 21.277 | 23.006.622 | Aufgestockt | +2,2% | |
| Perpetual Ltd | 909.546 | 910.630 | -1.084 | 21.428.904 | Reduziert | -0,1% | |
| Nuveen, LLC | 902.134 | 1.382.160 | -480.026 | 21.254.278 | Reduziert | -34,7% | |
| BNP PARIBAS FINANCIAL MARKETS | 812.146 | 699.803 | 112.343 | 19.134.160 | Aufgestockt | +16,1% | |
| MPM BioImpact LLC | 733.966 | 531.200 | 202.766 | 17.292.239 | Aufgestockt | +38,2% | |
| Qube Research & Technologies Ltd | 724.067 | 661.415 | 62.652 | 17.059.019 | Aufgestockt | +9,5% | |
| Aberdeen Group plc | 645.066 | 586.397 | 58.669 | 15.197.755 | Aufgestockt | +10,0% | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 636.200 | 900.000 | -263.800 | 14.988.872 | Reduziert | -29,3% | |
| Nearwater Capital Markets, Ltd | 607.300 | 615.000 | -7.700 | 14.307.988 | Reduziert | -1,3% | |
| Point72 Asset Management, L.P. | 590.877 | 425.152 | 165.725 | 13.921.062 | Aufgestockt | +39,0% | |
| Eversept Partners, LP | 576.580 | 434.634 | 141.946 | 13.584.225 | Aufgestockt | +32,7% | |
| FISHMAN JAY A LTD/MI | 566.730 | 564.650 | 2.080 | 13.352.159 | Aufgestockt | +0,4% | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 540.511 | 914.020 | -373.509 | 12.734.439 | Reduziert | -40,9% | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 503.856 | 125.979 | 377.877 | 11.870.847 | Aufgestockt | +300,0% | |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | 500.000 | 500.000 | 0 | 11.780.000 | Unverändert | 0,0% | |
| M&G Plc | 469.082 | 0 | 469.082 | 11.257.968 | Neu | +100,0% | |
| AQR CAPITAL MANAGEMENT LLC | 468.253 | 499.418 | -31.165 | 11.032.040 | Reduziert | -6,2% | |
| JANE STREET GROUP, LLC | 460.323 | 326.226 | 134.097 | 10.845.210 | Aufgestockt | +41,1% | |
| Cormorant Asset Management, LP | 450.000 | 500.000 | -50.000 | 10.602.000 | Reduziert | -10,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 440.999 | 273.999 | 167.000 | 10.389.936 | Aufgestockt | +60,9% | |
| STEMPOINT CAPITAL LP | 413.792 | 224.740 | 189.052 | 9.748.940 | Aufgestockt | +84,1% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 12.327.000 | 11.964.000 | +3,0% | 290.424.120 | 9,66 |
| Frazier Life Sciences Management, L.P. | 9.874.511 | 9.874.511 | 0,0% | 232.643.479 | 7,73 |
| BlackRock, Inc. | 9.200.411 | 9.099.579 | +1,1% | 216.761.686 | 7,21 |
| Rubric Capital Management LP | 8.271.577 | 8.271.577 | 0,0% | 194.878.354 | 6,48 |
| STATE STREET CORP | 6.296.197 | 5.488.301 | +14,7% | 148.338.401 | 4,93 |
| Polar Capital Holdings Plc | 5.666.940 | 5.556.169 | +2,0% | 133.513.106 | 4,44 |
| JENNISON ASSOCIATES LLC | 4.980.770 | 6.758.006 | -26,3% | 117.346.943 | 3,90 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.871.536 | 0 | +100,0% | 114.773.388 | 3,82 |
| GILDER GAGNON HOWE & CO LLC | 4.304.010 | 4.453.856 | -3,4% | 101.402.476 | 3,37 |
| MORGAN STANLEY | 4.218.931 | 4.340.239 | -2,8% | 99.398.031 | 3,30 |
| UBS Group AG | 3.329.224 | 3.243.432 | +2,6% | 78.436.518 | 2,61 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.045.306 | 2.753.307 | +10,6% | 71.759.223 | 2,39 |
| D. E. Shaw & Co., Inc. | 2.496.222 | 2.683.087 | -7,0% | 58.810.990 | 1,96 |
| MARSHALL WACE, LLP | 2.431.778 | 454.233 | +435,4% | 57.292.689 | 1,90 |
| FRANKLIN RESOURCES INC | 2.297.943 | 1.900.084 | +20,9% | 54.139.548 | 1,80 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2.226.029 | 2.562.445 | -13,1% | 52.445.243 | 1,74 |
| BANK OF AMERICA CORP /DE/ | 2.221.289 | 1.673.454 | +32,7% | 52.333.569 | 1,74 |
| JANUS HENDERSON GROUP PLC | 1.854.566 | 1.830.061 | +1,3% | 43.684.303 | 1,45 |
| GOLDMAN SACHS GROUP INC | 1.603.013 | 1.576.413 | +1,7% | 37.766.986 | 1,26 |
| AMERICAN CENTURY COMPANIES INC | 1.463.228 | 1.467.176 | -0,3% | 34.473.689 | 1,15 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 267 | 139,8 | 3.251 |
| 31.12.2025 | ✓ | 281 | 136,9 | 3.881 |
| 30.09.2025 | ✓ | 241 | 132,2 | 2.452 |
| 30.06.2025 | ✓ | 227 | 129,1 | 1.763 |
| 31.03.2025 | ✓ | 240 | 131,3 | 2.376 |
| 31.12.2024 | ✓ | 207 | 136,5 | 2.309 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 900.000 | 26.136.000 |
| OBERWEIS ASSET MANAGEMENT INC/ | 808.400 | 23.475.936 |
| Nearwater Capital Markets, Ltd | 615.000 | 17.859.600 |
| MPM BioImpact LLC | 531.200 | 15.426.048 |
| BAMCO INC /NY/ | 504.700 | 14.656.488 |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | 500.000 | 14.520.000 |
| Point72 Asset Management, L.P. | 425.152 | 12.346.414 |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 418.035 | 12.139.736 |
| CASTLEARK MANAGEMENT LLC | 309.430 | 8.985.847 |
| RENAISSANCE TECHNOLOGIES LLC | 273.999 | 7.956.931 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11.964.000 | 1.486.000 | +14.2 % | 347.434.560 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2.562.445 | 1.465.441 | +133.6 % | 74.413.403 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.166.348 | 1.078.546 | +1228.4 % | 33.872 |
| STATE STREET CORP | 5.488.301 | 846.986 | +18.2 % | 159.380.261 |
| BANK OF AMERICA CORP /DE/ | 1.673.454 | 784.169 | +88.2 % | 48.597.105 |
| BNP PARIBAS FINANCIAL MARKETS | 699.803 | 653.657 | +1416.5 % | 20.322.279 |
| D. E. Shaw & Co., Inc. | 2.683.087 | 564.374 | +26.6 % | 77.916.846 |
| DEUTSCHE BANK AG\ | 930.202 | 552.674 | +146.4 % | 27.013.066 |
| BlackRock, Inc. | 9.099.579 | 525.584 | +6.1 % | 264.251.774 |
| MARSHALL WACE, LLP | 454.233 | 435.933 | +2382.1 % | 13.190.928 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| JENNISON ASSOCIATES LLC | 6.758.006 | -5.496.113 | -44.9 % | 196.252.495 |
| Rubric Capital Management LP | 8.271.577 | -2.477.880 | -23.1 % | 240.206.596 |
| Perpetual Ltd | 910.630 | -1.113.976 | -55.0 % | 26.444.695 |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.366.624 | -753.884 | -35.6 % | 39.686.761 |
| JANUS HENDERSON GROUP PLC | 1.830.061 | -567.970 | -23.7 % | 53.154.122 |
| FRANKLIN RESOURCES INC | 1.900.084 | -410.935 | -17.8 % | 55.178.440 |
| JUPITER ASSET MANAGEMENT LTD | 326.538 | -332.793 | -50.5 % | 9.482.664 |
| MYDA Advisors LLC | 265.000 | -305.000 | -53.5 % | 7.695.600 |
| Cormorant Asset Management, LP | 500.000 | -275.000 | -35.5 % | 14.520.000 |
| GOLDMAN SACHS GROUP INC | 1.576.413 | -228.575 | -12.7 % | 45.779.034 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 12.05.2026 | STATE STREET CORPORATION | Passiv (13G) | 5,10 % | 6.296.197 | Neu | |
| 08.05.2026 | PRUDENTIAL FINANCIAL INC | Passiv (13G/A) | 4,30 % | 5.302.713 | -1,40 pp | |
| 06.05.2026 | Jennison Associates LLC | Passiv (13G/A) | 4,00 % | 4.980.770 | -1,50 pp | |
| 26.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -5,19 pp | |
| 13.02.2026 | PRUDENTIAL FINANCIAL INC | Passiv (13G/A) | 5,70 % | 7.079.926 | -4,40 pp | |
| 13.02.2026 | Rubric Capital Management LP | Passiv (13G/A) | 6,75 % | 8.271.577 | -0,29 pp | |
| 13.02.2026 | David Rosen | Passiv (13G/A) | 6,75 % | 8.271.577 | -2,63 pp | |
| 30.01.2026 | Jennison Associates LLC | Passiv (13G/A) | 5,50 % | 6.758.006 | -4,70 pp | |
| 06.10.2025 | Jennison Associates LLC | Passiv (13G/A) | 10,20 % | 12.254.119 | +0,60 pp | |
| 20.08.2025 | FHMLSP, L.P. | Aktivist (13D/A) | 0,60 % | 664.973 | Neu | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 20.08.2025 | Frazier Life Sciences X, L.P. | Aktivist (13D/A) | 0,00 % | 27.448 | Neu | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 20.08.2025 | Frazier Life Sciences XI, L.P. | Aktivist (13D/A) | 0,10 % | 73.087 | Neu | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 20.08.2025 | FHMLSP Overage, L.L.C. | Aktivist (13D/A) | 0,20 % | 196.170 | Neu | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 20.08.2025 | FHMLSP Overage, L.P. | Aktivist (13D/A) | 0,20 % | 196.170 | Neu | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 20.08.2025 | Frazier Life Sciences Public Overage Fund, L.P. | Aktivist (13D/A) | 0,20 % | 196.170 | Neu | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 20.08.2025 | FHMLS XII, L.L.C. | Aktivist (13D/A) | 0,10 % | 127.549 | Neu | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 20.08.2025 | FHM LIFE SCIENCES VIII, L.L.C. | Aktivist (13D/A) | 7,40 % | 8.785.291 | Neu | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 20.08.2025 | FHMLS X, L.L.C. | Aktivist (13D/A) | 0,00 % | 27.448 | Neu | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 20.08.2025 | FHMLS XI, L.P. | Aktivist (13D/A) | 0,10 % | 73.087 | Neu | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 20.08.2025 | James N. Topper | Aktivist (13D/A) | 7,40 % | 8.843.386 | -7,10 pp | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 20.08.2025 | Frazier Life Sciences Public Fund, L.P. | Aktivist (13D/A) | 0,60 % | 664.973 | Neu | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 20.08.2025 | Frazier Life Sciences XII, L.P. | Aktivist (13D/A) | 0,10 % | 127.549 | Neu | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 20.08.2025 | FHMLS X, L.P. | Aktivist (13D/A) | 0,00 % | 27.448 | Neu | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 20.08.2025 | Frazier Life Sciences VIII, L.P. | Aktivist (13D/A) | 7,30 % | 8.785.284 | -7,20 pp | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 20.08.2025 | FHM LIFE SCIENCES VIII, L.P. | Aktivist (13D/A) | 7,40 % | 8.785.284 | Neu | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 20.08.2025 | FHMLSP, L.L.C. | Aktivist (13D/A) | 0,60 % | 664.973 | Neu | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 20.08.2025 | Patrick J. Heron | Aktivist (13D/A) | 7,50 % | 8.943.712 | -7,10 pp | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 20.08.2025 | FHMLS XI, L.L.C. | Aktivist (13D/A) | 0,10 % | 73.087 | Neu | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 20.08.2025 | FHMLS XII, L.P. | Aktivist (13D/A) | 0,10 % | 127.549 | Neu | FLS VIII, FHM Life Sciences VIII, L.L.C, FLS X, FLSPF, FLSPOF, FLS XI and FLS XII each a… |
| 14.08.2025 | Polar Capital LLP | Passiv (13G/A) | 4,20 % | 5.006.472 | -1,45 pp | |
| 14.08.2025 | Polar Capital Funds PLC - Biotechnology Fund | Passiv (13G/A) | 4,20 % | 5.006.472 | -0,86 pp | |
| 14.08.2025 | Polar Capital Holdings Plc | Passiv (13G/A) | 4,20 % | 5.006.472 | -1,45 pp | |
| 15.05.2025 | Polar Capital Holdings Plc | Passiv (13G/A) | 5,65 % | 6.706.475 | -1,02 pp | |
| 15.05.2025 | Polar Capital Funds PLC - Biotechnology Fund | Passiv (13G/A) | 5,06 % | 6.000.000 | -0,77 pp | |
| 15.05.2025 | Polar Capital LLP | Passiv (13G/A) | 5,65 % | 6.706.475 | -1,02 pp | |
| 15.05.2025 | PRUDENTIAL FINANCIAL INC | Passiv (13G/A) | 10,10 % | 11.954.070 | Neu | |
| 08.05.2025 | Jennison Associates LLC | Passiv (13G/A) | 9,60 % | 11.360.875 | Neu | |
| 14.11.2024 | Cubist Systematic Strategies, LLC | Passiv (13G/A) | Ausstieg | 0 | -0,10 pp | |
| 14.11.2024 | Point72 Capital Advisors, Inc. | Passiv (13G/A) | 0,20 % | 247.055 | -4,90 pp | |
| 14.11.2024 | Point72 Asset Management, L.P. | Passiv (13G/A) | 0,20 % | 247.055 | -4,90 pp |
US Congress Trades (STOCK Act)
| Datum | Mitglied | Partei | Kammer | Typ | Betrag-Bereich |
|---|---|---|---|---|---|
| 29.05.2026 | Gilbert Cisneros | – | House | Kauf | $1,001 – $15,000 |
| 03.03.2026 | Gilbert Cisneros | – | House | Kauf | $1,001 – $15,000 |
Quelle: House eFD & Senate eFD (STOCK Act PTR). Betragsangaben sind Bereichsangaben — keine Exaktwerte. Tiefenanalyse für diese Aktie → · Alle Kongress-Bestände →
Stammdaten
Arcutis Biotherapeutics, Inc., ein biopharmazeutisches Unternehmen, konzentriert sich auf die Entwicklung und Vermarktung von Behandlungen für dermatologische Erkrankungen. Sein Lead-Produktkandidat ist ARQ-151, eine topische Roflumilast-Creme, die Phase-III-Kliniktests für die Behandlung von Plaquepsoriasis und atopischer Dermatitis abgeschlossen hat. Das Unternehmen entwickelt auch ARQ-154, eine topische Schaum-Formulierung von Roflumilast zur Behandlung von seborrhoischer Dermatitis und Kopfhaut-Psoriasis; ARQ-252, einen selektiven topischen Janus-Kinase-Typ-1-Inhibitor für Handekzem und Vitiligo; und ARQ-255, eine topische Formulierung von ARQ-252, die dazu bestimmt ist, tiefer in die Haut vorzudringen, um Alopecia areata (kreisrunden Haarausfall) zu behandeln. Das Unternehmen hieß früher Arcutis, Inc. und änderte seinen Namen im Oktober 2019 in Arcutis Biotherapeutics, Inc. Arcutis Biotherapeutics, Inc. wurde 2016 gegründet und hat seinen Sitz in Westlake Village, Kalifornien.
Unternehmen & Branche
| Name | Arcutis Biotherapeutics, Inc. |
|---|---|
| Ticker | ARQT |
| CIK | 0001787306 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 03969K108 |
|---|---|
| ISIN | US03969K1088 |
| Typ | Common Stock |
| Marktkapitalisierung | 3,03 Mrd. USD |
| Beta | 1,53 |
Bewertung
| KBV (P/B) | 16,01 vs. 3,50 (2021) ▲ |
|---|---|
| KUV (P/S) | 8,06 |
| FCF-Rendite | -0,2 % vs. -16,8 % (2021) ▲ |
Qualität & Bilanz
| Bruttomarge | 90,2 % |
|---|---|
| Operative Marge | -3,3 % |
| Nettomarge | -4,3 % |
| ROIC | -5,3 % vs. -55,0 % (2021) ▲ |
| Zinsdeckungsgrad | -1,0 |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 3,50 | 4,31 | 3,53 | 10,42 | 18,90 | |
| KUV (P/S) | – | 245,08 | 5,24 | 8,35 | 9,52 | |
| FCF-Rendite | -16,8 % | -28,6 % | -79,2 % | -6,8 % | -0,2 % | |
| Qualität & Bilanz | ||||||
| Bruttomarge | – | 79,5 % | 91,6 % | 90,3 % | 90,2 % | |
| Operative Marge | – | -8.183,0 % | -404,5 % | -65,3 % | -3,3 % | |
| Nettomarge | – | -8.449,8 % | -439,8 % | -71,3 % | -4,3 % | |
| ROIC | -55,0 % | -75,6 % | -89,0 % | -52,2 % | -5,3 % | |
| Zinsdeckungsgrad | – | -19,3 | -8,1 | -4,7 | -1,0 | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 105.398.000 | -11.295.000 | -0,09 | 460.003.000 | 189.648.000 |
| 2025-12-31 | 10-K | 376.072.000 | -16.141.000 | -0,13 | 432.973.000 | 189.479.000 |
| 2025-09-30 | 10-Q | 99.219.000 | 7.410.000 | 0,06 | 370.977.000 | 158.073.000 |
| 2025-06-30 | 10-Q | 81.504.000 | -15.886.000 | -0,13 | 352.433.000 | 138.974.000 |
| 2025-03-31 | 10-Q | 65.846.000 | -25.060.000 | -0,20 | 344.105.000 | 142.658.000 |
| 2024-12-31 | 10-K | 196.542.000 | -140.039.000 | -1,16 | 348.889.000 | 157.541.000 |
| 2024-09-30 | 10-Q | 44.755.000 | -41.537.000 | -0,33 | 437.354.000 | 156.641.000 |
| 2024-06-30 | 10-Q | 30.858.000 | -52.332.000 | -0,42 | 444.759.000 | 186.427.000 |
| 2024-03-31 | 10-Q | 49.569.000 | -35.382.000 | -0,32 | 478.541.000 | 224.942.000 |
| 2023-12-31 | 10-K | 59.606.000 | -262.140.000 | -3,78 | 341.365.000 | 88.667.000 |
| 2023-09-30 | 10-Q | 38.109.000 | -44.765.000 | -0,73 | 292.959.000 | 46.717.000 |
| 2023-06-30 | 10-Q | 5.190.000 | -70.991.000 | -1,16 | 320.689.000 | 80.508.000 |
| 2023-03-31 | 10-Q | 2.781.000 | -80.100.000 | -1,31 | 379.458.000 | 139.732.000 |
| 2022-12-31 | 10-K | 3.686.000 | -311.458.000 | -5,66 | 449.274.000 | 209.581.000 |
| 2022-09-30 | 10-Q | -107.709.000 | -1,89 | 508.914.000 | 270.774.000 | |
| 2022-06-30 | 10-Q | 0 | -67.406.000 | -1,31 | 300.464.000 | 195.382.000 |
| 2022-03-31 | 10-Q | -64.324.000 | -1,27 | 364.109.000 | 253.772.000 | |
| 2021-12-31 | 10-K | -206.356.000 | -4,18 | 408.152.000 | 297.677.000 | |
| 2021-09-30 | 10-Q | -56.980.000 | -1,14 | 387.008.000 | 362.995.000 | |
| 2021-06-30 | 10-Q | -42.008.000 | -0,84 | 432.892.000 | 414.488.000 |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2025 | FY 2024 | FY 2023 | FY 2022 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|
| ZORYVEFoam | 181,9 Mio. | 71,5 Mio. | – | – | 48,9 % | +154,3% | |
| ZORYVECream 0.3 | 121,0 Mio. | 85,1 Mio. | 29,2 Mio. | 3,7 Mio. | 32,5 % | +42,2% | |
| ZORYVECream 0.15 | 68,3 Mio. | 9,9 Mio. | – | – | 18,3 % | +588,2% | |
| ZORYVECream 0.05 | 911.000 | – | – | – | 0,2 % | Neu |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 06.05.2026 | 105,4 Mio. USD | -0,09 |
| Q3 2025 | 30.09.2025 | 28.10.2025 | 99,2 Mio. USD | 0,06 |
| Q2 2025 | 30.06.2025 | 28.10.2025 | 81,5 Mio. USD | -0,13 |
| Q1 2025 | 31.03.2025 | 06.05.2026 | 65,8 Mio. USD | -0,20 |
| Q3 2024 | 30.09.2024 | 28.10.2025 | 44,8 Mio. USD | -0,33 |
| Q2 2024 | 30.06.2024 | 28.10.2025 | 30,9 Mio. USD | -0,42 |
| Q1 2024 | 31.03.2024 | 28.10.2025 | 49,6 Mio. USD | -0,32 |
| Q3 2023 | 30.09.2023 | 06.11.2024 | 38,1 Mio. USD | -0,73 |
| Q2 2023 | 30.06.2023 | 06.11.2024 | 5,2 Mio. USD | -1,16 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 06.05.2026 | 10-Q | 31.03.2026 | 36 Tage | SEC » |
| 25.02.2026 | 10-K | 31.12.2025 | 56 Tage | SEC » |
| 28.10.2025 | 10-Q | 30.09.2025 | 28 Tage | SEC » |
| 06.08.2025 | 10-Q | 30.06.2025 | 37 Tage | SEC » |
| 06.05.2025 | 10-Q | 31.03.2025 | 36 Tage | SEC » |
| 25.02.2025 | 10-K | 31.12.2024 | 56 Tage | SEC » |
| 06.11.2024 | 10-Q | 30.09.2024 | 37 Tage | SEC » |
| 14.08.2024 | 10-Q | 30.06.2024 | 45 Tage | SEC » |
| 24.07.2024 | 10-Q/A | 31.03.2024 | 115 Tage | SEC » |
| 14.05.2024 | 10-Q | 31.03.2024 | 44 Tage | SEC » |
| 27.02.2024 | 10-K | 31.12.2023 | 58 Tage | SEC » |
| 03.11.2023 | 10-Q | 30.09.2023 | 34 Tage | SEC » |
| 15.09.2023 | 10-K/A | 31.12.2022 | 258 Tage | SEC » |
| 15.09.2023 | 10-Q/A | 30.06.2023 | 77 Tage | SEC » |
| 15.09.2023 | 10-Q/A | 31.03.2023 | 168 Tage | SEC » |
| 08.08.2023 | 10-Q | 30.06.2023 | 39 Tage | SEC » |
| 09.05.2023 | 10-Q | 31.03.2023 | 39 Tage | SEC » |
| 28.02.2023 | 10-K | 31.12.2022 | 59 Tage | SEC » |
| 08.11.2022 | 10-Q | 30.09.2022 | 39 Tage | SEC » |
| 04.08.2022 | 10-Q | 30.06.2022 | 35 Tage | SEC » |
| 05.05.2022 | 10-Q | 31.03.2022 | 35 Tage | SEC » |
| 03.03.2022 | 10-K/A | 31.12.2021 | 62 Tage | SEC » |
| 22.02.2022 | 10-K | 31.12.2021 | 53 Tage | SEC » |
| 04.11.2021 | 10-Q | 30.09.2021 | 35 Tage | SEC » |
| 05.08.2021 | 10-Q | 30.06.2021 | 36 Tage | SEC » |
| 06.05.2021 | 10-Q | 31.03.2021 | 36 Tage | SEC » |
| 16.02.2021 | 10-K | 31.12.2020 | 47 Tage | SEC » |
| 05.11.2020 | 10-Q | 30.09.2020 | 36 Tage | SEC » |
| 11.08.2020 | 10-Q | 30.06.2020 | 42 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 08.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 10.04.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 15.02.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 27.09.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 07.09.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 18.08.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 24.05.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 29.07.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-14 | 1.982 | 21,69 | 42.990 |
| 2026-05-13 | 14.724 | 20,69 | 304.640 |
| 2026-04-30 | 57 | 22,37 | 1.275 |
| 2026-04-21 | 4.150 | 24,47 | 101.551 |
| 2026-04-20 | 175 | 24,53 | 4.293 |
| 2026-04-14 | 462 | 24,12 | 11.143 |
| 2026-03-30 | 990 | 21,22 | 21.008 |
| 2026-03-18 | 1.449 | 22,72 | 32.921 |
| 2026-03-17 | 41 | 22,76 | 933 |
| 2026-03-06 | 1 | 23,97 | 24 |
| 2026-02-26 | 6 | 27,01 | 162 |
| 2026-02-25 | 7 | 26,98 | 189 |
| 2026-02-24 | 1 | 26,31 | 26 |
| 2026-01-21 | 21.771 | 25,87 | 563.216 |
| 2026-01-16 | 2.738 | 26,36 | 72.174 |
| 2026-01-05 | 542 | 29,00 | 15.718 |
| 2025-12-29 | 1 | 28,97 | 29 |
| 2025-12-22 | 4.025 | 28,01 | 112.740 |